Father of Codeine Trafficking Kingpin Arrested at Airport
Kolkata Police arrests Bhola Prasad, father of absconding pharmaceutical dealer Shubham Jaiswal, in UP's multi-state codeine trafficking investigation. Read the full story.
Category : Search result: pharmaceutical policy
UP busts ₹150 crore pharma narcotics racket
Uttar Pradesh authorities uncover massive pharmaceutical diversion network smuggling codeine-based cough syrups as narcotics across 7 states and borders. 87 firms face FIRs in chilling organized crime operation.
NCB Issues Warrants in ₹600 Crore Drug Racket
NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.
12 Pharma Firms Booked in UP Cough Syrup Smuggling Case
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
Freudenberg's Pharma Innovations at CPhI PMEC India 2025
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Highlights Pharma Innovations at CPhI PMEC 2025
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma Shares Jump 33% After Strong IPO Listing
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma IPO Lists Today with Strong Grey Market Premium
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO Allotment Status Today
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma IPO Subscribed 94 Times
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Global Tenders for 65+ Patented Drugs in India
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Ramaswamy's net worth jumps 80% to $1.8 billion
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister's Directive to Pharma Industry
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US Trade Deal: $500B Target & Stock Gains
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Pakistan Factory Boiler Blast Kills 15 in Punjab
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Summit 2025: Pharma Partnerships for India's Growth
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India Sends 3.5 Tonnes Medical Aid to Seychelles
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Karnataka Unveils IT, SpaceTech & Startup Policy 2025-2030
Karnataka launches ambitious IT, SpaceTech and Startup Policy 2025-2030, targeting 50% national market share and 5% global SpaceTech presence by 2034. Read more about the state's tech vision.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Evexia Lifecare Share Price Rises 3% on High Volumes
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Page 1 of 4